TY - JOUR
T1 - A nationwide population-based prospective study of cirrhosis in Iceland
AU - Olafsson, Sigurdur
AU - Rögnvaldsson, Sigurjon
AU - Bergmann, Ottar M.
AU - Jonasson, Jon G.
AU - Benitez Hernandez, Ubaldo
AU - Björnsson, Einar S.
N1 - © 2021 The Author(s).
PY - 2021/6/1
Y1 - 2021/6/1
N2 - Background & Aims: The incidence of cirrhosis in Iceland has been the lowest in the world with only 3 cases per 100,000 inhabitants. Alcohol consumption has almost doubled in Iceland from 1980 to 2016. Obesity has also risen and hepatitis C virus has spread among people who inject drugs in Iceland. The aim of this study was to evaluate the effects of these risk factors on the incidence and aetiology of cirrhosis in Iceland. Methods: The study included all patients diagnosed with cirrhosis for the first time during 2010–2015. Diagnosis was based on liver histology or 2 of 4 criteria: cirrhosis on imaging, ascites, varices, and/or elevated INR. Results: Overall, 157 patients were diagnosed, 105 (67%) males, mean age 61 years. The overall incidence was 9.7 cases per 100,000 inhabitants annually. Alcohol was the only underlying cause in 48/157 (31%), non-alcoholic fatty liver disease (NAFLD) in 34/157(22%), and alcohol and hepatitis C together in 23/157(15%) were the most common causes. Only 6% of patients had an unknown cause of cirrhosis. Upon diagnosis, the median model for end-stage liver disease score was 11 (IQR 8–15), 53% were of Child-Pugh class A whereas 61 (39%) had ascites, 11% encephalopathy, and 8% variceal bleeding. In all, 25% of deaths were from HCC and 25% from liver failure. Conclusion: A major increase in incidence of cirrhosis has occurred in Iceland associated with increases in alcohol consumption, obesity, and hepatitis C. In a high proportion NAFLD was the aetiology and very few had unknown cause of cirrhosis. The highest death rate was from HCC. Lay summary: In a nationwide population-based study from Iceland, including all patients diagnosed with cirrhosis of the liver over a period of 5 years, we found the incidence of new cases had increased 3-fold compared with a previous study 20 years ago. The increase is attributable to increased alcohol consumption, an epidemic of diabetes and obesity, and infection with the hepatitis C virus. Furthermore, we found that with thorough investigations, a specific cause for cirrhosis could be found in 94% of patients. Patients with cirrhosis frequently die of liver cancer and other complications related to their liver disease.
AB - Background & Aims: The incidence of cirrhosis in Iceland has been the lowest in the world with only 3 cases per 100,000 inhabitants. Alcohol consumption has almost doubled in Iceland from 1980 to 2016. Obesity has also risen and hepatitis C virus has spread among people who inject drugs in Iceland. The aim of this study was to evaluate the effects of these risk factors on the incidence and aetiology of cirrhosis in Iceland. Methods: The study included all patients diagnosed with cirrhosis for the first time during 2010–2015. Diagnosis was based on liver histology or 2 of 4 criteria: cirrhosis on imaging, ascites, varices, and/or elevated INR. Results: Overall, 157 patients were diagnosed, 105 (67%) males, mean age 61 years. The overall incidence was 9.7 cases per 100,000 inhabitants annually. Alcohol was the only underlying cause in 48/157 (31%), non-alcoholic fatty liver disease (NAFLD) in 34/157(22%), and alcohol and hepatitis C together in 23/157(15%) were the most common causes. Only 6% of patients had an unknown cause of cirrhosis. Upon diagnosis, the median model for end-stage liver disease score was 11 (IQR 8–15), 53% were of Child-Pugh class A whereas 61 (39%) had ascites, 11% encephalopathy, and 8% variceal bleeding. In all, 25% of deaths were from HCC and 25% from liver failure. Conclusion: A major increase in incidence of cirrhosis has occurred in Iceland associated with increases in alcohol consumption, obesity, and hepatitis C. In a high proportion NAFLD was the aetiology and very few had unknown cause of cirrhosis. The highest death rate was from HCC. Lay summary: In a nationwide population-based study from Iceland, including all patients diagnosed with cirrhosis of the liver over a period of 5 years, we found the incidence of new cases had increased 3-fold compared with a previous study 20 years ago. The increase is attributable to increased alcohol consumption, an epidemic of diabetes and obesity, and infection with the hepatitis C virus. Furthermore, we found that with thorough investigations, a specific cause for cirrhosis could be found in 94% of patients. Patients with cirrhosis frequently die of liver cancer and other complications related to their liver disease.
KW - Aetiology of cirrhosis
KW - Alcohol
KW - Cirrhosis
KW - Hepatitis C
KW - Incidence of cirrhosis
KW - NAFLD
KW - AIH, autoimmune hepatitis
KW - ALD, alcoholic liver disease
KW - CIF, cumulative incidence function
KW - CRR, competing-risks regression
KW - HCC, hepatocellular carcinoma
KW - MELD, model for end-stage liver disease
KW - NAFLD, non-alcoholic fatty liver disease
KW - NALD, non-alcoholic liver disease
KW - NASH, non-alcoholic steatohepatitis
KW - PBC, primary biliary cirrhosis
KW - PSC, primary sclerosing cholangitis
KW - SHRs, subhazard ratios
KW - Liver Cirrhosis
KW - AIH, autoimmune hepatitis
KW - ALD, alcoholic liver disease
KW - Aetiology of cirrhosis
KW - Alcohol
KW - CIF, cumulative incidence function
KW - CRR, competing-risks regression
KW - Cirrhosis
KW - HCC, hepatocellular carcinoma
KW - Hepatitis C
KW - Incidence of cirrhosis
KW - MELD, model for end-stage liver disease
KW - NAFLD
KW - NAFLD, non-alcoholic fatty liver disease
KW - NALD, non-alcoholic liver disease
KW - NASH, non-alcoholic steatohepatitis
KW - PBC, primary biliary cirrhosis
KW - PSC, primary sclerosing cholangitis
KW - SHRs, subhazard ratios
KW - Liver Cirrhosis
UR - http://www.scopus.com/inward/record.url?scp=85106227815&partnerID=8YFLogxK
U2 - 10.1016/j.jhepr.2021.100282
DO - 10.1016/j.jhepr.2021.100282
M3 - Article
C2 - 34041467
AN - SCOPUS:85106227815
SN - 2589-5559
VL - 3
SP - 100282-Skorpulifur
JO - JHEP Reports
JF - JHEP Reports
IS - 3
M1 - 100282
ER -